The risk of miscarriage after COVID-19 vaccination before and during pregnancy.

de Feijter, Maud; van Gelder, Marleen M H J; Vissers, Lieke C M; Kant, Agnes C; Woestenberg, Petra J

de Feijter, Maud; van Gelder, Marleen M H J; Vissers, Lieke C M; Kant, Agnes C; Woestenberg, Petra J.

Affiliation

de Feijter M; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
van Gelder MMHJ; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
Vissers LCM; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
Kant AC; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
Woestenberg PJ; Department of Clinical Pharmacology and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.

Pharmacoepidemiol Drug Saf ; 33(1): e5724, 2024 Jan.

Article in En | MEDLINE | ID: mdl-37946587

Subject(s)

Abortion, Spontaneous; COVID-19; Pregnancy; Female; Humans; Adult; Abortion, Spontaneous/chemically induced; Abortion, Spontaneous/epidemiology; COVID-19 Vaccines/adverse effects; Cohort Studies; COVID-19/epidemiology; COVID-19/prevention & control; SARS-CoV-2; Vaccination/adverse effects

Key words

COVID-19; miscarriage; pregnancy; prospective cohort; vaccination safety

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Abortion, Spontaneous / COVID-19 Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google